Citadel Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.1M Sell
740,800
-668,700
-47% -$59.6M 0.01% 1150
2025
Q4
$111M Buy
1,409,500
+644,900
+84% +$50.6M 0.02% 787
2025
Q3
$61.1M Buy
764,600
+150,300
+24% +$12.8M 0.01% 1201
2025
Q2
$55.8M Sell
614,300
-228,700
-27% -$20.9M 0.01% 1157
2025
Q1
$79M Buy
843,000
+280,600
+50% +$25.1M 0.02% 837
2024
Q4
$51.1M Buy
562,400
+7,900
+1% +$754K 0.01% 1255
2024
Q3
$57.6M Sell
554,500
-24,900
-4% -$2.54M 0.01% 1082
2024
Q2
$56.2M Sell
579,400
-199,500
-26% -$18.4M 0.01% 1065
2024
Q1
$70.1M Buy
778,900
+164,300
+27% +$13.9M 0.01% 960
2023
Q4
$49M Sell
614,600
-229,800
-27% -$17.3M 0.01% 1205
2023
Q3
$60M Buy
844,400
+456,000
+117% +$34.1M 0.01% 929
2023
Q2
$29.9M Sell
388,400
-1,109,500
-74% -$85.9M 0.01% 1477
2023
Q1
$113M Buy
1,497,900
+430,000
+40% +$32M 0.02% 563
2022
Q4
$84.1M Buy
1,067,900
+346,500
+48% +$26M 0.02% 744
2022
Q3
$50.7M Buy
721,400
+286,200
+66% +$22.4M 0.01% 1063
2022
Q2
$34.9M Sell
435,200
-44,400
-9% -$3.47M 0.01% 1327
2022
Q1
$36.4M Sell
479,600
-183,400
-28% -$14.5M 0.01% 1372
2021
Q4
$56.6M Buy
663,000
+168,000
+34% +$13.1M 0.01% 1075
2021
Q3
$37.4M Sell
495,000
-8,600
-2% -$683K 0.01% 1349
2021
Q2
$41M Buy
503,600
+88,900
+21% +$7.27M 0.01% 1300
2021
Q1
$32.7M Buy
414,700
+9,500
+2% +$745K 0.01% 1433
2020
Q4
$34.6M Sell
405,200
-335,600
-45% -$27.8M 0.01% 1262
2020
Q3
$57.2M Buy
740,800
+6,000
+0.8% +$457K 0.02% 769
2020
Q2
$53.8M Buy
734,800
+439,400
+149% +$31.2M 0.02% 756
2020
Q1
$19.6M Sell
295,400
-50,900
-15% -$3.59M 0.01% 1249
2019
Q4
$23.8M Buy
346,300
+46,200
+15% +$3.15M 0.01% 1323
2019
Q3
$22.1M Buy
300,100
+16,400
+6% +$1.19M 0.01% 1379
2019
Q2
$20.3M Buy
283,700
+25,300
+10% +$1.8M 0.01% 1413
2019
Q1
$17.7M Sell
258,400
-59,700
-19% -$3.86M 0.01% 1448
2018
Q4
$18.9M Sell
318,100
-100,500
-24% -$6.29M 0.01% 1277
2018
Q3
$28M Buy
418,600
+78,600
+23% +$5.24M 0.01% 1130
2018
Q2
$22M Buy
340,000
+185,400
+120% +$12.1M 0.01% 1232
2018
Q1
$11.1M Sell
154,600
-69,300
-31% -$4.99M 0.01% 1618
2017
Q4
$16.9M Sell
223,900
-14,600
-6% -$1.07M 0.01% 1274
2017
Q3
$17.4M Sell
238,500
-245,600
-51% -$17.7M 0.01% 1171
2017
Q2
$35.9M Buy
484,100
+172,100
+55% +$12.8M 0.03% 658
2017
Q1
$22.8M Buy
312,000
+74,400
+31% +$5.21M 0.02% 858
2016
Q4
$15.5M Sell
237,600
-223,800
-49% -$15.3M 0.02% 1040
2016
Q3
$34.2M Buy
461,400
+269,700
+141% +$19.9M 0.03% 575
2016
Q2
$14M Buy
191,700
+20,400
+12% +$1.45M 0.02% 1007
2016
Q1
$12.1M Buy
171,300
+87,800
+105% +$5.84M 0.02% 1048
2015
Q4
$5.56M Sell
83,500
-133,900
-62% -$8.91M 0.01% 1722
2015
Q3
$13.8M Buy
217,400
+21,800
+11% +$1.42M 0.01% 1131
2015
Q2
$12.8M Buy
195,600
+36,800
+23% +$2.5M 0.01% 1299
2015
Q1
$11M Sell
158,800
-500
-0.3% -$34.6K 0.01% 1366
2014
Q4
$11M Sell
159,300
-28,200
-15% -$1.9M 0.01% 1337
2014
Q3
$12.2M Buy
187,500
+58,800
+46% +$3.88M 0.01% 1231
2014
Q2
$8.78M Sell
128,700
-25,700
-17% -$1.72M 0.01% 1374
2014
Q1
$10M Sell
154,400
-45,300
-23% -$2.85M 0.01% 1265
2013
Q4
$13M Sell
199,700
-20,000
-9% -$1.28M 0.02% 1053
2013
Q3
$13M Sell
219,700
-231,500
-51% -$13.7M 0.02% 948
2013
Q2
$25.8M Buy
+451,200
New +$26.8M 0.04% 521

Other funds holding CL

Citadel Advisors's CL Position: Q1 2026 in Review

Citadel Advisors reduced its Colgate-Palmolive (CL) stake by 56% in Q1 2026, selling an estimated $360M and leaving 3,183,995 shares worth $271M. The position accounts for 0.04% of the portfolio, ranked #333.

Citadel Advisors first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $571M in Q4 2025. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Citadel Advisors held 3,183,995 shares of Colgate-Palmolive worth $271M as of Q1 2026.
  • Citadel Advisors sold 4,040,509 Colgate-Palmolive shares in Q1 2026, an estimated $360M.
  • Colgate-Palmolive made up 0.04% of Citadel Advisors's portfolio in Q1 2026, its #333 holding.
  • Citadel Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Colgate-Palmolive position peaked at $571M in Q4 2025.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.